Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO Pre-Tax Margin

Income before tax as a percentage of revenue.

No reported Pre-Tax Margin figures are available to summarize.

Pre-Tax Margin history

Percent of revenue · from the income statement

No Pre-Tax Margin data reported for this period type.

Pre-Tax Margin vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors Peer median
Pre-Tax Margin for LTGO and competitors
Company Period LTM level YoY 3-year change
COLLCollegium Pharmaceutical, Inc.LTM Mar 202613.6% +3.8 pp+18.1 pp
PCRXPacira BioSciences, Inc.LTM Mar 20261.8% +11.5 pp+0.3 pp
SCLXScilex Holding CompanyLTM Mar 2026-1162.4% -1015.4 pp-1174.9 pp
LTGOLatigo Biotherapeutics Inc.—— ——
Peer median (excluding LTGO) 1.8%+3.8 pp+0.3 pp

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.